	US 12,144,909 B2
	Bone repair composition and kit
Jeffrey Johnson, Flowood, MS (US); Nels J Lauritzen, Piscataway, NJ (US); and Brent Mitchell, Haskell, NJ (US)
Assigned to ZAVATION MEDICAL PRODUCTS, LLC, Flowood, MS (US)
Filed by Zavation Medical Products, LLC, Flowood, MS (US)
Filed on Dec. 29, 2020, as Appl. No. 17/136,584.
Application 17/136,584 is a continuation of application No. 16/230,399, filed on Dec. 21, 2018, granted, now 11,090,412.
Prior Publication US 2021/0113738 A1, Apr. 22, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/38 (2006.01); A61F 2/28 (2006.01); A61L 24/02 (2006.01); A61L 27/12 (2006.01); A61L 27/24 (2006.01); A61L 27/46 (2006.01); A61L 27/54 (2006.01)

CPC A61L 27/3847 (2013.01) [A61F 2/28 (2013.01); A61L 27/12 (2013.01); A61L 27/24 (2013.01); A61L 27/54 (2013.01); A61F 2002/2817 (2013.01); A61L 24/02 (2013.01); A61L 27/46 (2013.01); A61L 2300/414 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01)]

21 Claims

1. A bone repair composition, comprising

a particulate dispersion comprising a strip product and comprising a collagen component, a bone growth stimulator, and a bioactive glass,

wherein

the bioactive glass ranges from 15% to 25% by weight of the particulate dispersion and comprises bioactive glass particles having a size from 250 to 2000 microns,

the bone growth stimulator comprising calcium phosphate ranges from 75% to 85% by weight of the particulate dispersion and comprises bone growth stimulator particles having a size from 250 to 2500 microns,

the collagen component ranges from 0.5% to 10% by weight of the particulate dispersion, and

the strip product contains no hydroxyapatite in its formulation.